MoU signed to boost Singapore’s precision medicine initiative
SINGAPORE: National Supercomputing Center (NSCC) Singapore and the Singapore government-backed Global Gene Corp (GGC) recently signed an agreement to bolster the country’s genomics-driven precision medicine initiative. The colaboration will help GGC deliver “the first ever genomic beacon for Indian population”, the company said.
GGC is a genomics data platform and applications company. The NSCC supports high performance scientific and engineering computing needs in Singapore. The country’s ‘Precision Medicine Initiative’ leverages advanced computing technology to help clinicians determine genetic risk factors and predict the likelihood of developing cardiovascular disease.
The collaboration will allow GGC and NSCC to use each other’s expertise to create the next generation supercomputing infrastructure for genomic precision medicine.
“As a Singapore origin company, we are delighted to partner with NSCC to achieve the ambition of democratising healthcare through genomics…This partnership represents a strategic collaboration building on our work to deliver ggcINDIA, the first ever genomic beacon for Indian population in collaboration with GA4GH”, said Sumit S Jamuar, chairman & CEO of Global Gene Corp.
“We are delighted to embark on this collaboration with Global Gene Corp, a Singapore company with support from Singapore’s Economic Development Board. While we are already backing initiatives in genomics-driven precision medicine with high performance computing capabilities, we also want to boost projects with wider aspirations,” executive director of Singapore’s NSCC Tin Wee Tan said.
Source: The Times of India